EVENITY romosozumab 105 mg/1.17 mL injection solution syringe with a pen injector (2023-24)
Product name
EVENITY romosozumab 105 mg/1.17 mL injection solution syringe with a pen injector
Sponsor name
Amgen Australia Pty Ltd
Year Range
2023-24